Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Champix smoking cessation in young adults with asthma
2010-024208-81Phase 4Completed
- Sponsor
- Abzu
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varenicline in nicotine dependence and asthma, sponsored by Abzu. Primary endpoint: Change in sputum inflammatory cell pattern. Started Jan 2011; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependenceasthma
Beyond the preview
Go deeper on 2010-024208-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024208-81.